Man X - Search Results

1

Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in China.

Wang P, Wang B, Zhang L, Liu X, Shi L, Kang X, Lei X, Chen K, Chen Z, Li C, Zhang C, Tu P, Pan M, Ju Q, Man X, Lu Y, Yu N, Li Y, Zhu H, Zhang R, Su J, Tao S, Qiao J, Mu Q, Zeng W, Li Z, Gao Y, Gu H, Wang X. Wang P, et al. Among authors: man x. Photodiagnosis Photodyn Ther. 2023 Mar;41:103261. doi: 10.1016/j.pdpdt.2022.103261. Epub 2022 Dec 30. Photodiagnosis Photodyn Ther. 2023. PMID: 36587863 Review.

2

Gradually increasing the dosing interval of Secukinumab for moderate to severe plaque psoriasis: A single-center, uncontrolled, prospective study in 36 weeks.

Chen XB, Zheng YX, Ye LR, Chen XY, Man XY. Chen XB, et al. Dermatol Ther. 2022 Dec;35(12):e15911. doi: 10.1111/dth.15911. Epub 2022 Oct 17. Dermatol Ther. 2022. PMID: 36209377 Free PMC article.

3

Targeting VEGF/VEGFR in the treatment of psoriasis.

Li W, Man XY, Chen JQ, Zhou J, Cai SQ, Zheng M. Li W, et al. Discov Med. 2014 Sep;18(98):97-104. Discov Med. 2014. PMID: 25227750 Free article. Review.

4

The staged forearm and leg interpolation flap in the treatment of cutaneous squamous cell carcinoma: A retrospective case series.

Chen XY, Tao LE, Yan BX, Man XY. Chen XY, et al. Dermatol Ther. 2022 May;35(5):e15398. doi: 10.1111/dth.15398. Epub 2022 Mar 1. Dermatol Ther. 2022. PMID: 35194899 No abstract available.

5

Biologics for psoriasis patients under 18 years of age: Real-world evidence from the Chinese psoriasis real world evidence research group.

Zheng YX, Ye LR, Yan BX, Chen SQ, Cai SQ, Man XY. Zheng YX, et al. Front Med (Lausanne). 2022 Sep 7;9:1009991. doi: 10.3389/fmed.2022.1009991. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36160145 Free PMC article.

6

Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series.

Sun YH, Man XY, Xuan XY, Huang CZ, Shen Y, Lao LM. Sun YH, et al. Dermatol Ther. 2022 Nov;35(11):e15848. doi: 10.1111/dth.15848. Epub 2022 Oct 10. Dermatol Ther. 2022. PMID: 36175135

7

Local hyperthermia as a good treatment option for hands and feet warts in children: Case series report.

Wang T, Zhou W, Man X, Li W. Wang T, et al. Among authors: man x. Dermatol Ther. 2022 Dec;35(12):e15936. doi: 10.1111/dth.15936. Epub 2022 Oct 21. Dermatol Ther. 2022. PMID: 36227625 No abstract available.

8

Dupilumab as a novel therapy for bullous pemphigoid.

Zhang X, Man X, Tang Z, Dai R, Shen Y. Zhang X, et al. Among authors: man x. Int J Dermatol. 2023 Apr;62(4):e263-e266. doi: 10.1111/ijd.16525. Epub 2022 Nov 28. Int J Dermatol. 2023. PMID: 36440691 No abstract available.

9

The treatment of refractory atypical bullous pemphigoid with generalized eczema and intense pruritus with dupilumab.

Li W, Cai S, Man X. Li W, et al. Among authors: man x. Dermatol Ther. 2022 Feb;35(2):e15243. doi: 10.1111/dth.15243. Epub 2021 Dec 9. Dermatol Ther. 2022. PMID: 34854196 No abstract available.

10

Immunotherapy in atopic dermatitis.

Li W, Man XY. Li W, et al. Immunotherapy. 2022 Oct;14(14):1149-1164. doi: 10.2217/imt-2022-0054. Epub 2022 Aug 31. Immunotherapy. 2022. PMID: 36046941 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page